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Chapter 1: Introduction
Eighty – eight years ago (in 1928) penicillin, “the miracle drug”, was discovered. It was
until 1942 that penicillin was used to successfully treat a civilian patient. [1] Since then modern
medicine has given us vaccines for the flu, pneumonia, and meningitis; allowed us to transplant
hearts, kidneys, and lungs; and enabled us to sequence the human genome. [2] Even with all of
these incredible advances in technology, currently most delivery systems are still non-selective,
meaning the drug harms healthy cells as well as disease cells. The damage to healthy cells is
what leads to the undesirable side effects caused by many medicines today. By designing a
selective delivery system such as peptoid nanospheres, drug side effects could be drastically
reduced and possibly eliminated.

Chapter 2: Background
Section 2.1: Peptoids
Peptoids are poly-N-substituted glycines as shown in Figure 1. [3] By using peptoids
instead of peptides, protease degradation can be avoided. [4] Protease degradation is
particularly concerning for this application because the goal is to deliver medicine to diseased
cells. If protease degradation were to occur, the medicine would be released before reaching
the desired destination rendering the targeting mechanism useless.

Figure 1. Peptoids vs. Peptides [4]
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Another benefit of peptoids is that peptoid alpha helixes have a three pitch turn
meaning every third side chain stacks precisely on top of the previous one. [5] This allows the
charges to align on one side which is believed to aid in nanosphere formation.

Section 2.2: Peptoid Selection
Having the side chain bonded to the nitrogen makes the backbone achiral but chirality is
needed for peptoid formation. To induce chirality, large chiral side chains are used. Peptoids
were chosen such that two aromatic rings are followed by a charged side chain. Two positively
charged side chains followed by two negatively charged side chains were used because previous
research showed this sequence was most likely to induce nanosphere formation. An example
structure is shown in Figure Figure 2: Peptoid Sequence2.
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Figure 2: Peptoid Sequence
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Section 2.3: Mechanism Theory
The peptoids will be used to form nanospheres then the nanospheres will be attached
to peptoids known to bind to specific proteins found at much higher concentrations or
exclusively on diseased cells. The peptoid nanospheres will form tertiary structures, as shown in
Figure 3, which will allow them to form spheres. The aromatic rings will stack on two sides and
the charges align on the third.

Figure 3: Peptoid Sphere Formation [5]
The peptoid nanospheres will then be attached to affinity peptoids which will target the
diseased cells as shown in Figure 4. Upon binding, the medicine will be released at the disease
site. The medicine could be released in the cells due to endocytosis. If endocytosis does not
occur, the medicine could be released using an external source such as heat or ultrasound.

Figure 4: Targeting Mechanism
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Chapter 3: Methods
Before conducting experiments, the peptoids were synthesized then purified to greater
than 98% using high performance liquid chromatography. Matrix assisted laser desorption
ionization was used to confirm the peptoids synthesized properly by verifying the molecular
weight. Circular dichroism was used to determine the helicity before proceeding with
nanosphere testing. Scanning electron microscopy showed if peptoids formed on a solid
substrate. Finally, dynamic light scattering in conjunction with transmission electron microscopy
was used to determine if spheres formed in solution.

Section 3.1: Peptoid Synthesis
Peptoid synthesis is a submonomer process that begins with an amine group attached
to a rink amide resin. [6] The resin is swelled using 40 mL of dimethylformamide (DMF) per 1
mmol of resin determined by weight, then drained. The Fmoc group is then deprotected using
20% piperdine in DMF at 40 mL/mmol concentration. This step is repeated to ensure the Fmoc
group is completely deprotected. The resin is then rinsed using DMF at 40 mL/mmol five times.
To begin the submonomer process, 1.2 molar bromoacetic acid at a concentration of 17
mL/mmol resin is used to acylate the amine. This is done in the presence of
diisopropylcarbodiimide (DIC) at a concentration of 3.2 mL/mmol resin. The resin is rinsed three
times with 40 mL/mmol DMF before 17 mL/mmol of a 1 molar solution of the desired side chain,
typically in DMF, is added to the solution. The bromine is displaced by the desired sidechain
using an SN2 mechanism. This process is repeated until the desired peptoid is synthesized.
Before the peptoid can be used it must be cleaved from the resin. To begin this process
the peptoid on resin is dissolved in 10 mL of a 95% trifluoroacetic acid (TFA), 2.5%
triisopropylsilane, and 2.5% water solution then swirled for ten minutes. Immediately the
peptoid solution is filtered to remove the resin beads then rotary evaporated. Once the sample
6

has reached an oily state in the rotary evaporator, it is dissolved in just enough 50/50
acetonitrile and water mixture to have a concentration of 3 mg/mL based off the original sample
weight.

Section 3.2: High Performance Liquid Chromatography
High performance liquid chromatography (HPLC) was used to purify the sample then
analytical HPLC was analyzed to determine the purity of the sample. Before using the HPLC, all
solvents were sparged with hydrogen for 30 min to ensure no air entered the column. Once
sparging was complete, solvent A (94.5% water, 5% acetonitrile, and 0.5% (TFA) was run for 10
minutes followed by 10 minutes of solvent B (94.5% acetonitrile, 5% water, and 0.5% TFA) then
the column was equilibrated with starting conditions for 10 minutes. Three milliliters of 3
mg/mL peptoid dissolved in 50/50 acetonitrile and water was injected into the HPLC then a 1%
gradient per minute from 30 to 95% acetonitrile was run. Ultraviolet light was used to
determine when peptoid was leaving the column and these samples were collected. The
collected samples were analyzed using analytical HPLC and matrix assisted laser desorption
ionization.

Section 3.3: Matrix Assisted Laser Desorption Ionization
Matrix assisted laser desorption ionization (MALDI) was used to confirm the correct
peptoid was synthesized. To perform MALDI, 1 μl of peptoid sample was mixed with 1 μl of DHB
matrix then dried on a metal plate. Standards were ran before testing the samples. The
molecular weight estimated by MALDI was then compared to the predicted molecular weight to
determine if the peptoid synthesized properly.

Section 3.4: Circular Dichroism
Circular dichroism determines the relative helicity of the peptoids by comparing the
difference in light absorption between left and right circularly polarized light. The circular
7

dichroism value was calculated by subtracting the right circularly polarized light from the left
circularly polarized light. [7] This experimental value was then compared to known values to
determine the peptoid structure.

Section 3.5: Scanning Electron Microscopy
Scanning electron microscopy (SEM) uses an electron beam to form an image of a
surface. [8] The anode directs the electron beam down the column towards the specimen as
shown in Figure 5. [9] The beam then proceeds through a series of magnetic lenses. The
condenser lens controls the spot size and an objective lens controls where the beam comes into
focus. The stagnator makes the electron beam round before it contacts the sample. [10] When
the electrons hit the sample, electrons and x-rays are emitted. [9] Detectors collect data from
each of these emissions and convert it to a signal which is used to construct an image of the
surface. [8]

Figure 5: Scanning Electron Microscope [8]
For SEM, samples must be conductive and completely dry. SEM is performed under a
vacuum to prevent air molecules from interfering with the electron beam. If water is present in
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the sample, it will vaporize and disrupt the equipment. Non-metal samples must be sputter
coated with a conductive material. [8]
The peptoid samples were dried on silicon chips at room temperature for 30 minutes
then sputter coated with gold before being imaged. These images were used to determine if
spheres formed on the surface of a dry substrate.

Section 3.6: Dynamic Light Scattering
Dynamic light scattering (DLS) predicts the size of spherical particles in solution. The
instrument sends a laser beam through the sample as shown in Figure 6. It then measures the
transmitted light shown as “PD” in the figure and scattered light at either 90° or 173° depending
on the concentration of the particles. This data is used to determine the size of the particles in
solution. [11]

Figure 6: Dynamic Light Scattering Set-up [11]
The particles are assumed to be in Brownian motion therefore the probability density
function is known. Using the transmitted and scattered light data, the diffusion constant can be
calculated with the probability density function. Stokes-Einstein relation can then be applied
based on the assumption that the particles are small. This yields an equation for the diffusion
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constant that is based on the particle radius, the Boltzmann constant, temperature, and the
viscosity of the solvent. [12]
To conduct this experiment, each peptoid was dissolved in a 4 to 1 ethanol and water
solution at 3 mg/mL. The program used the light intensity data to calculate volume and the
number of particles for each diameter.

Section 3.7: Transmission Electron Microscopy
To perform transmission electron microscopy (TEM), 1 µL of 3 mg/ mL peptoid dissolved
in a 4 to 1 methanol and water solution was mixed with 1 µL 1% uranyl acetate and dried on
copper mesh at room temperature for 24 hours. Once dried, the samples were viewed using
TEM, which is similar to SEM except the transmitted light is detected instead of the scattered
light. [13]
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Chapter 4: Results
The peptoids were synthesized then purified using HPLC. MALDI was used to determine
if the peptoids were properly synthesized. Analytical HPLC was performed to ensure the
peptoids were above 98% pure. The peptoids tested during this study are shown in Table 1
below.
Table 1: Peptoid Sequences
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Section 4.1: Circular Dichroism
Based on previous research conducted in the Servoss lab, in order for nanosphere
formation to occur, peptoids need to form a polyproline type 1-like helix. All four peptoids were
determined to have this secondary structure based on their minima around 200 and 220 nm. [5]
Figure 7 shows typical circular dichroism results from literature and Figure 8 shows the results
obtained by another student in Servoss’s lab for the peptoids used in this study.

Figure 7: Circular Dichroism Literature Values [14]

Figure 8: Circular Dichroism Results [5]
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Section 4.2: Scanning Electron Microscopy
Scanning electron microscopy was used to determine if peptoid nanospheres formed on
a solid substrate. This experiment was performed previously then redone before testing the
peptoids further. The figure below shows representative SEM images for the four peptoids
tested. P3 was the only peptoid that showed uniform sphere formation when dried on a solid
substrate.

Figure 9: SEM Images A) P1 (scale bar = 5 µm) B) wP1 (scale bar = 10 µm) C) rP1 (scale bar = 5
µm) D) P3 (scale bar = 10 µm)
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Section 4.3: Dynamic Light Scattering
Dynamic light scattering was used to determine the size of particles in solution. The
graphs with multiple peaks were determined to not form uniform spheres in solution because
either they formed spheres of multiple sizes or the particles were different sizes in different
directions. The peptoids with a single DLS peak were tested using transmission electron
microscopy.

Figure 10: DLS Data
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Section 4.4: Transmission Electron Microscopy
Transmission electron microscopy was performed on two of the peptoids. One of the
peptoids, P3, formed spheres which were analyzed using Image J. The data from Image J was
averaged in excel. P3 was found to have an average diameter of around 500 nm.

Figure 11: TEM Images
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Chapter 5: Discussion
The scanning electron microscopy showed if spheres formed when dried on a solid
substrate. To determine if the spheres formed in solution or during the drying process, dynamic
light scattering and transmission electron microscopy tests were performed. The TEM images
were analyzed and the average diameter was determined. This was compared to the diameters
predicted by DLS. These were approximately 500 nm and 600 nm respectively. Because the
diameters were less than 20 % different, it can be assumed that the spheres formed in solution.
The error could be due to the inaccuracy of using ImageJ to estimate the size of the spheres, but
it is more likely due to error in the DLS calculations. DLS accounts for solvent properties when
making size predictions. For these tests a pure solvent was not used; however, DLS was set to
use the properties of pure methanol for its predictions. This mixture would change the viscosity
of the solvent which would change the size predictions.

Chapter 6: Conclusion
While all four peptoids appear to be forming secondary structures, only one of the
peptoids formed nanospheres in solution. This indicates that although helicity may be required
for nanospheres formation, it is not the only factor. Peptoids are protease resistant and can be
manipulated to carry drugs to the disease site. Based on these results peptoids show promise as
a drug delivery system.

Chapter 7: Recommendations
To build on this study the peptoids should also be tested in other solvents. Specifically,
the peptoids should be tested in a biocompatible solvent and in the presence of salts.
Determining if the spheres are stable in the body is key for them to be used for drug delivery.
Using the knowledge gained from these experiments, new peptoids can be designed that are
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more biocompatible and more stable in the body. The spheres should then be attached to a
peptoid that is known to target VGFR. DLS and TEM should be repeated to determine if VGFR
interferes with sphere formation.
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